80 0019 Pill — YELLOW OVAL, 17mm — Pravastatin

No photo available

Imprint	80 / 0019
Colour	YELLOW
Shape	OVAL
Size	17
Strength	—
Dosage form	Tablet
Manufacturer	Watson Laboratories, Inc.
NDC	0591-0019
Schedule	—
Availability	—
Ingredients	—

What does this imprint mean?

The imprint "80 0019" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Pravastatin

Uses and warnings

No boxed warning. Contraindications include "hypersensitivity to any component of this medication," "active liver disease or unexplained, persistent elevations of serum transaminases," and use during pregnancy and lactation. Key warnings cover skeletal muscle effects - patients should report "unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever" - with rare cases of "rhabdomyolysis with acute renal failure secondary to myoglobinuria," and rare immune-mediated necrotizing myopathy (IMNM) with "proximal muscle weakness and elevated serum creatine kinase, which persist despite discontinuation of statin treatment."

Pravastatin is indicated to reduce the risk of MI, revascularization, and cardiovascular mortality in hypercholesterolemic patients without clinically evident coronary heart disease, and in patients with existing coronary heart disease to reduce "the risk of total mortality by reducing coronary death, MI, revascularization, stroke/TIA, and the progression of coronary atherosclerosis." Also indicated as an adjunct to diet for elevated total cholesterol, LDL-C, and triglycerides, and for "heterozygous familial hypercholesterolemia" in pediatric patients 8 years and older who fail diet therapy.

Read the full drug profile →